NOS2 Regulation of LPS-induced Airway Inflammation Via S-nitrosylation of NF-{kappa}B P65
Overview
Molecular Biology
Physiology
Pulmonary Medicine
Authors
Affiliations
Inducible nitric oxide synthase (NOS2) expression is increased in the airway epithelium in acute inflammatory disorders although the physiological impact remains unclear. We have previously shown that NOS2 inhibits NF-κB (p50-p65) activation in respiratory epithelial cells by inducing S-nitrosylation of the p65 monomer (SNO-p65). In addition, we have demonstrated that mouse lung SNO-p65 levels are acutely depleted in a lipopolysaccharide (LPS) model of lung injury and that augmenting SNO-p65 levels before LPS treatment results in decreased airway epithelial NF-κB activation, airway inflammation, and lung injury. We now show that aerosolized LPS induces NOS2 expression in the respiratory epithelium concomitant with an increase in lung SNO-p65 levels and a decrease in airway NF-κB activity. Genetic deletion of NOS2 results in an absence of SNO-p65 formation, persistent NF-κB activity in the respiratory epithelium, and prolonged airway inflammation. These results indicate that a primary function of LPS-induced NOS2 expression in the respiratory epithelium is to modulate the inflammatory response through deactivation of NF-κB via S-nitrosylation of p65, thereby counteracting the initial stimulus-coupled denitrosylation.
Hu R, Zhang F, Ma Q, Ehsan M, Zhao Q, Zhu X PLoS Negl Trop Dis. 2022; 16(3):e0010286.
PMID: 35320269 PMC: 8942208. DOI: 10.1371/journal.pntd.0010286.
Aguilar G, Koning T, Ehrenfeld P, Sanchez F Front Physiol. 2020; 11:595526.
PMID: 33281627 PMC: 7691576. DOI: 10.3389/fphys.2020.595526.
Khan M, Singh P, Dohare R, Jha R, Rahmani A, Almatroodi S Genes (Basel). 2020; 11(9).
PMID: 32825525 PMC: 7563942. DOI: 10.3390/genes11090966.
Consequences of Hypoxia for the Pulmonary Alveolar Epithelial Cell Innate Immune Response.
Sturrock A, Woller D, Freeman A, Sanders K, Paine 3rd R J Immunol. 2018; 201(11):3411-3420.
PMID: 30381478 PMC: 6246786. DOI: 10.4049/jimmunol.1701387.
Nevoral J, Bodart J, Petr J Oxid Med Cell Longev. 2016; 2016:1730750.
PMID: 27579148 PMC: 4992752. DOI: 10.1155/2016/1730750.